Drug interactions for the following drug(s)

Add New Drugs

Interactions between your selected drugs

Moderate

paroxetine<>polyethylene glycol 3350

Applies to: PAXIL CR 12.5 MG 24HR Extended Release Oral Tablet <> Miralax 17 GM per 4 OZ Powder for Oral Solution

The therapeutic efficacy of Polyethylene glycol can be decreased when used in combination with Paroxetine.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

Interactions between your selected drugs

Moderate

paroxetine<>polyethylene glycol 3350

Applies to: PAXIL CR 12.5 MG 24HR Extended Release Oral Tablet <> Miralax 17 GM per 4 OZ Powder for Oral Solution

Drug1 (rxcui = 1738804, name = 24 HR paroxetine hydrochloride 12.5 MG Extended Release Oral Tablet [Paxil], tty = SBD). Drug2 (rxcui = 876195, name = polyethylene glycol 3350 17000 MG Powder for Oral Solution [Miralax], tty = SBD). Drug1 is resolved to paroxetine, Drug2 is resolved to polyethylene glycol 3350 and interaction asserted in DrugBank between Paroxetine and Polyethylene glycol.

No other interactions were found between your selected drugs.

Note: this does not necessarily mean no interactions exist. Always consult with your doctor or pharmacist.

DrugInteractionChecker.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex® (updated Sep 28th, 2016), Cerner Multum™ (updated Oct 2nd, 2016), Wolters Kluwer™ (updated Oct 1st, 2016) and others. To view content sources and attributions, please refer to our editorial policy.